FRACTIONAL CO2 TECHNOLOGY- INTIMA
Interest in women’s intimate wellness, including treating vulvar disease (inflammatory, ulcerative, and blistering disorders, as well as pigmentary changes and atrophy) and modifying the cosmetic appearance of the vulva (sagging skin, pigmentation, texture), is steadily increasing.1,2 Treatment for vulvar disease is intended to address the associated symptoms, including: itching; burning; painful sexual intercourse; thickened or thin skin on the vulva, and stinging or irritation.
1. Cihantimur B, Herold C. Genital beautification: a concept that offers more than reduction of the labia minora. Aesthetic Plast Surg. 2013;37(6):1128-33.
2. Schwartz RA. Benign vulvar lesions. At: http:// emedicine.medscape.com/article/264648- overview. Accessed Nov. 11, 2015.
Changes in genitourinary anatomy and physiology can adversely affect female sexual health and quality of life over a woman’s lifetime. Common medical conditions due to childbirth or age-related changes include Vaginal Relaxation Syndrome (VRS), Stress Urinary Incontinence (SUI), the Genitourinary Syndrome of Menopause and Vulvar and Vaginal Atrophy (VVA). Vaginal laxity, mild to moderate SUI and symptoms of increased dryness, itching, burning and dyspareunia result in discomfort and problems with intimacy and sexual satisfaction for many women.1,2
1. Palacios S, et al. Update on management of genitourinary syndrome of menopause: A practical guide. Maturitas (2015), http://dx.doi.org/10.1016/j.maturitas.2015.07.020
2. Pauls RN, et al. Vaginal laxity: a poorly understood quality of life problem; a survey of physician members of the International Urogynecological Association (IUGA). Int Urogynecol J. 2012. DOI 10.1007/ s00192-012-1757-4.